Prevalence of Hyperlipidaemia Among Adults During the Last Three Years at Murjan Hospital, Hilla City

Background: Hyperlipidemia is marked by reduced high-density lipoprotein and elevated triglycerides, total cholesterol, and low-density lipoprotein cholesterol. It begins with endothelial damage, triggering inflammation and lipid accumulation in artery walls, leading to fibrous plaques that may rupture and cause thrombosis or arterial blockage, worsening cardiovascular disease. Management includes lifestyle changes and drugs such as statins, fibrates, niacin, PCSK9 inhibitors, and ezetimibe. Aim: To examine the relationship between hyperlipidemia and age and gender, identify risk factors and health consequences, and provide preventive and therapeutic insights. Materials and Methods: This retrospective study analyzed 17,660 adults (aged 20–70) with hyperlipidemia—7,064 females and 10,596 males—using laboratory records from Murjan Hospital in Hilla City (2022–2024). Data were assessed using descriptive statistics (frequencies and percentages). Results: Cases were distributed as 33% (2022), 33% (2023), and 34% (2024). Lipid abnormalities were notably more frequent in older than younger age groups. Of the total sample, 7,064 (40%) were female and 10,596 (60%) were male. Conclusion: Hyperlipidemia is linked to age and gender. Aging-related metabolic changes and reduced physical activity increase risk, while men show higher harmful lipid levels during early and mid-adulthood.